This list is an analysis based on recent market events. It's not an investment recommendation.
About
VivoPower PLC, along with its various subsidiaries, operates as a global provider of sustainable energy solutions, primarily serving markets in the United Kingdom, Australia, Southeast Asia, and the United States. The company organizes its business activities into four distinct divisions: Critical Power Services, Electric Vehicles, Sustainable Energy Solutions, and Solar Development. The Critical Power Services division offers extensive energy infrastructure solutions, covering both power generation and distribution. This includes the conceptualization, sourcing, installation, and continuous upkeep of sophisticated power and control systems for a diverse clientele, ranging from governmental bodies to commercial enterprises and industrial operators. Its Electric Vehicles segment designs and manufactures resilient, lightweight electric vehicle solutions, tailored for demanding industries such as mining, infrastructure, utilities, and government service providers. The Sustainable Energy Solutions segment is dedicated to the design, assessment, commercialization, and deployment of renewable energy infrastructure. This division also specializes in evaluating advanced solar, battery storage, and microgrid technologies. Lastly, the Solar Development segment manages the complete lifecycle of photovoltaic (PV) solar projects, from their initial inception and development to construction, securing financial backing, ongoing operation, performance enhancement, and ultimate sale. This segment currently oversees a portfolio of 12 operational solar projects. Established in 2014, VivoPower PLC maintains its corporate headquarters in London, United Kingdom.
Depending on the exchange, the stock ticker may vary. For instance, on Boerse Stuttgart exchange Meridian Bioscience stocks are traded under the ticker MR4.STU.
When is the next Meridian Bioscience earnings date?▼
Meridian Bioscience is going to release the next earnings report on August 31, 2026.
What were Meridian Bioscience earnings last quarter?▼
MR4.STU earnings for the last quarter are -0.86 EUR per share, whereas the estimation was N/A EUR resulting in a N/A surprise. The estimated earnings for the next quarter are N/A EUR per share.
What is Meridian Bioscience revenue for the last year?▼
Meridian Bioscience revenue for the last year amounts to 59,170.67 EUR.
What is Meridian Bioscience net income for the last year?▼
MR4.STU net income for the last year is -11.38M EUR.
Does Meridian Bioscience pay dividends?▼
Yes, MR4.STU dividends are paid quarterly. The last dividend per share was 0.11 EUR. As of today, Dividend Yield (FWD)% is 0%.
How many employees does Meridian Bioscience have?▼
As of July 11, 2026, the company has 92 employees.
In which sector is Meridian Bioscience located?▼
Meridian Bioscience operates in the Other sector.
When did Meridian Bioscience complete a stock split?▼
Meridian Bioscience has not had any recent stock splits.
Where is Meridian Bioscience headquartered?▼
Meridian Bioscience is headquartered in London, United Kingdom.